{"id":2434,"date":"2011-02-23T15:45:23","date_gmt":"2011-02-23T15:45:23","guid":{"rendered":"https:\/\/medicalcriteria.com\/web\/candtc\/"},"modified":"2025-05-14T19:08:25","modified_gmt":"2025-05-14T19:08:25","slug":"candtc","status":"publish","type":"post","link":"https:\/\/medicalcriteria.com\/web\/es\/candtc\/","title":{"rendered":"Indicaciones y Contraindicaciones del Tratamiento con Yodo Radiactivo del C\u00e1ncer de Tiroides Diferenciado (CDT)"},"content":{"rendered":"<div class=\"7ca9444b8380138fe077da07353677a4\" data-index=\"1\" style=\"float: none; margin:0px 0 0px 0; text-align:center;\">\n<script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js\"><\/script>\r\n<!-- MC 2019- Horizontal -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-0127150553352455\"\r\n     data-ad-slot=\"3806776041\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script>\n<\/div>\n<p><\/p>\n<div>\n<div>El c\u00e1ncer diferenciado de tiroides (CDT) se define como un carcinoma derivado del epitelio folicular y la retenci\u00f3n de caracter\u00edsticas biol\u00f3gicas b\u00e1sicas de tejido tiroideo sano, incluida la expresi\u00f3n del cotransportador de yoduro\/sodio (NIS), la caracter\u00edstica clave de celular para la captaci\u00f3n de yodo espec\u00edfico.<\/div>\n<div><!--more--><\/div>\n<div>El tratamiento con yodo radioactivo (RAIT) se define como la administraci\u00f3n sist\u00e9mica de yoduro 131 s\u00f3dico o yoduro de potasio (I<sup><sub>131<\/sub><\/sup>) para la irradiaci\u00f3n selectiva de restos tiroideos, CDT microsc\u00f3picos o CDT irresecable o resecci\u00f3n incompleta, o ambos efectos.<\/div>\n<div><\/div>\n<div><strong>Indicaciones y contraindicaciones del tratamiento con yodo radiactivo de CDT\u00a0<\/strong><\/div>\n<div><\/div>\n<div>A. Indicaciones\u00a0definitivas<\/div>\n<div>1. Met\u00e1stasis en ganglios linf\u00e1ticos no resecables yodo-\u00e1vidos en uno o m\u00e1s de las siguientes situaciones:<\/div>\n<ul>\n<li>im\u00e1genes morfol\u00f3gicas que no detectan la ubicaci\u00f3n<\/li>\n<li>riesgo quir\u00fargico elevado o contraindicaci\u00f3n de la misma<\/li>\n<li>compromiso a distancia presente que indica de todos modos RAIT<\/li>\n<\/ul>\n<div>2. Micromet\u00e1stasis pulmonares yodo-\u00e1vidos, sobre todo antes de que sean visibles en la TC<\/div>\n<div>3. Macromet\u00e1stasis pulmonares yodo-\u00e1vidos no resecables o parcialmente resecables<\/div>\n<div>4. Met\u00e1stasis en tejidos blandos yodo-\u00e1vidos no resecables o parcialmente resecables<\/div>\n<div><\/div>\n<div>B. Indicaciones opcionales<br \/>\n1. Met\u00e1stasis a distancia o ganglios linf\u00e1ticos yodo \u00e1vidos recurrentes, como adyuvante a la cirug\u00eda<br \/>\n2. Met\u00e1stasis en ganglios linf\u00e1ticos yodo-\u00e1vidos no resecables en una o m\u00e1s de las siguientes situaciones:<\/div>\n<ul>\n<li>peque\u00f1o\u00a0tama\u00f1o<\/li>\n<li>compromete numerosos ganglios linf\u00e1ticos o est\u00e1 muy extendida<\/li>\n<\/ul>\n<div>3. Met\u00e1stasis \u00f3seas \u00e1vidas de yodo no resecables o parcialmente resecables, sobre todo cuando son sintom\u00e1ticas o amenazan estructuras vitales<\/div>\n<div>4. Conocimiento o sospecha de met\u00e1stasis de CDT, cuando la avidez al yodo no se conoce todav\u00eda, especialmente si Tg es detectable o se incrementa<sup>a<\/sup><\/div>\n<div>5. Carcinomas de tiroides pobremente diferenciados o anapl\u00e1sicos con zonas bien diferenciadas (relevantes) o que expresan Tg, especialmente si es sintom\u00e1tica o progresiva<sup>b\u00a0<\/sup><\/div>\n<div><\/div>\n<div>C. No est\u00e1 indicado en:<\/div>\n<ol>\n<li>Met\u00e1stasis de ganglios linf\u00e1ticos no \u00e1vidos de yodo<\/li>\n<li>Macromet\u00e1stasis pulmonar no \u00e1vidos de yodo<\/li>\n<li>Met\u00e1stasis \u00f3seas no \u00e1vidos de yodo<\/li>\n<\/ol>\n<div><\/div>\n<div>D. Contraindicaciones<\/div>\n<ol>\n<li>Embarazo<\/li>\n<li>Lactancia materna<\/li>\n<li>Depresi\u00f3n de la m\u00e9dula \u00f3sea cl\u00ednicamente relevante cuando la hiperactividad de la RAIT est\u00e1 prevista (contraindicaci\u00f3n relativa)<\/li>\n<li>Restricci\u00f3n de la funci\u00f3n pulmonar cl\u00ednicamente relevante junto con la acumulaci\u00f3n importante esperada en la met\u00e1stasis pulmonar (contraindicaci\u00f3n relativa)<\/li>\n<li>Restricci\u00f3n de gl\u00e1ndulas salivales cl\u00ednicamente relevante, especialmente si la acumulaci\u00f3n de I<sup>131<\/sup>\u00a0en las lesiones conocidas es cuestionable (contraindicaci\u00f3n relativa)<\/li>\n<\/ol>\n<div><\/div>\n<div>Abreviaturas:<\/div>\n<div>TC, tomograf\u00eda computarizada, CDT, carcinoma diferenciado de tiroides; I<sup>131<\/sup>, yodo 131; RAIT, terapia de yodo radioactivo, Tg,\u00a0tiroglobulina<\/div>\n<div><\/div>\n<div>Notas:<\/div>\n<div><sup>a<\/sup>\u00a0Estos pacientes deben recibir un curso inicial de RAIT, y si el scan de cuerpo entero post-tratamiento es negativo, la RAIT debe interrumpirse.<\/div>\n<div><sup>b<\/sup>\u00a0En estos pacientes, la indicaci\u00f3n de\u00a0<span class=\"short_text\"><span class=\"hps\">radioterapia<\/span>\u00a0<span class=\"hps\">de haz<\/span>\u00a0<span class=\"hps\">externo<\/span><\/span>\u00a0y la urgencia de RAIT deben ser considerados en la decisi\u00f3n sobre si se debe administrar RAIT.<\/div>\n<div><\/div>\n<div><\/div>\n<\/div>\n<p><strong>Bibliograf\u00eda:<\/strong><\/p>\n<div>\n<ol>\n<li>Luster M, Clarke SE, Dietlein M, Lassmann M, Lind P, Oyen WJ, Tennvall J, Bombardieri E; European Association of Nuclear Medicine (EANM). Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1941-59. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18670773\/\" target=\"_blank\" rel=\"noopener noreferrer\">[Medline]<\/a><\/li>\n<li>Jonklaas J, Cooper DS, Ain KB, Bigos T, Brierley JD, Haugen BR, Ladenson PW, Magner J, Ross DS, Skarulis MC, Steward DL, Maxon HR, Sherman SI; National Thyroid Cancer Treatment Cooperative Study Group. Radioiodine therapy in patients with stage I differentiated thyroid cancer. Thyroid. 2010 Dec;20(12):1423-4. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21054207\/\" target=\"_blank\" rel=\"noopener noreferrer\">[Medline]<\/a><\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<p>Creado: Feb 23, 2011.<\/p>\n<\/div>\n<p><\/p>\n\n<div style=\"font-size: 0px; height: 0px; line-height: 0px; margin: 0; padding: 0; clear: both;\"><\/div>","protected":false},"excerpt":{"rendered":"<p>El c\u00e1ncer diferenciado de tiroides (CDT) se define como un carcinoma derivado del epitelio folicular y la retenci\u00f3n de caracter\u00edsticas biol\u00f3gicas b\u00e1sicas de tejido tiroideo sano, incluida la expresi\u00f3n del cotransportador de yoduro\/sodio (NIS), la caracter\u00edstica clave de celular para la captaci\u00f3n de yodo espec\u00edfico.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"no","_lmt_disable":"no","_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[272],"tags":[322,1005,1004,1233,1232,1231,74,73,1230,1229,511,513,261,1234],"class_list":["post-2434","post","type-post","status-publish","format-standard","hentry","category-oncology","tag-cancer","tag-contraindicaciones","tag-contraindications","tag-diferenciado","tag-differentiated","tag-dtc","tag-indicaciones","tag-indications","tag-iodo","tag-radioiodine","tag-thyroid","tag-tiroides","tag-tratamiento","tag-yodo"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Indicaciones y Contraindicaciones del Tratamiento con Yodo Radiactivo del C\u00e1ncer de Tiroides Diferenciado (CDT) - MedicalCRITERIA.com<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/medicalcriteria.com\/web\/candtc\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"[:es]Indicaciones y Contraindicaciones del Tratamiento con Yodo Radiactivo del C\u00e1ncer de Tiroides Diferenciado (CDT)[:en]Indications and Contraindications Radioiodine Treatment of Differentiated Thyroid Cancer (DTC)[:] - MedicalCRITERIA.com\" \/>\n<meta property=\"og:description\" content=\"El c\u00e1ncer diferenciado de tiroides (CDT) se define como un carcinoma derivado del epitelio folicular y la retenci\u00f3n de caracter\u00edsticas biol\u00f3gicas b\u00e1sicas de tejido tiroideo sano, incluida la expresi\u00f3n del cotransportador de yoduro\/sodio (NIS), la caracter\u00edstica clave de celular para la captaci\u00f3n de yodo espec\u00edfico.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medicalcriteria.com\/web\/candtc\/\" \/>\n<meta property=\"og:site_name\" content=\"MedicalCRITERIA.com\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/medicalcriteria\/\" \/>\n<meta property=\"article:published_time\" content=\"2011-02-23T15:45:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-14T19:08:25+00:00\" \/>\n<meta name=\"author\" content=\"Guillermo Firman\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Guillermo Firman\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/candtc\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/candtc\\\/\"},\"author\":{\"name\":\"Guillermo Firman\",\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/#\\\/schema\\\/person\\\/ead6734a2f20659131388ba822c7078c\"},\"headline\":\"Indicaciones y Contraindicaciones del Tratamiento con Yodo Radiactivo del C\u00e1ncer de Tiroides Diferenciado (CDT)\",\"datePublished\":\"2011-02-23T15:45:23+00:00\",\"dateModified\":\"2025-05-14T19:08:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/candtc\\\/\"},\"wordCount\":1081,\"publisher\":{\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/#organization\"},\"keywords\":[\"Cancer\",\"contraindicaciones\",\"Contraindications\",\"diferenciado\",\"Differentiated\",\"DTC\",\"indicaciones\",\"Indications\",\"iodo\",\"Radioiodine\",\"Thyroid\",\"tiroides\",\"tratamiento\",\"yodo\"],\"articleSection\":[\"Oncology\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/candtc\\\/\",\"url\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/candtc\\\/\",\"name\":\"[:es]Indicaciones y Contraindicaciones del Tratamiento con Yodo Radiactivo del C\u00e1ncer de Tiroides Diferenciado (CDT)[:en]Indications and Contraindications Radioiodine Treatment of Differentiated Thyroid Cancer (DTC)[:] - MedicalCRITERIA.com\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/#website\"},\"datePublished\":\"2011-02-23T15:45:23+00:00\",\"dateModified\":\"2025-05-14T19:08:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/candtc\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/candtc\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/candtc\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Indicaciones y Contraindicaciones del Tratamiento con Yodo Radiactivo del C\u00e1ncer de Tiroides Diferenciado (CDT)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/#website\",\"url\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/\",\"name\":\"MedicalCRITERIA.com\",\"description\":\"Unifying Concepts\",\"publisher\":{\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/#organization\",\"name\":\"MedicalCRITERIA.com\",\"url\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/cropped-mc_1024x500.png\",\"contentUrl\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/cropped-mc_1024x500.png\",\"width\":600,\"height\":257,\"caption\":\"MedicalCRITERIA.com\"},\"image\":{\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/medicalcriteria\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/#\\\/schema\\\/person\\\/ead6734a2f20659131388ba822c7078c\",\"name\":\"Guillermo Firman\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/24f0f68ba780b5b240680962755c6f75e6116e6667394a46e38b7b8fd0a62e9f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/24f0f68ba780b5b240680962755c6f75e6116e6667394a46e38b7b8fd0a62e9f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/24f0f68ba780b5b240680962755c6f75e6116e6667394a46e38b7b8fd0a62e9f?s=96&d=mm&r=g\",\"caption\":\"Guillermo Firman\"},\"sameAs\":[\"http:\\\/\\\/MedicalCRITERIA.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"[:es]Indicaciones y Contraindicaciones del Tratamiento con Yodo Radiactivo del C\u00e1ncer de Tiroides Diferenciado (CDT)[:en]Indications and Contraindications Radioiodine Treatment of Differentiated Thyroid Cancer (DTC)[:] - MedicalCRITERIA.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/medicalcriteria.com\/web\/candtc\/","og_locale":"es_ES","og_type":"article","og_title":"[:es]Indicaciones y Contraindicaciones del Tratamiento con Yodo Radiactivo del C\u00e1ncer de Tiroides Diferenciado (CDT)[:en]Indications and Contraindications Radioiodine Treatment of Differentiated Thyroid Cancer (DTC)[:] - MedicalCRITERIA.com","og_description":"El c\u00e1ncer diferenciado de tiroides (CDT) se define como un carcinoma derivado del epitelio folicular y la retenci\u00f3n de caracter\u00edsticas biol\u00f3gicas b\u00e1sicas de tejido tiroideo sano, incluida la expresi\u00f3n del cotransportador de yoduro\/sodio (NIS), la caracter\u00edstica clave de celular para la captaci\u00f3n de yodo espec\u00edfico.","og_url":"https:\/\/medicalcriteria.com\/web\/candtc\/","og_site_name":"MedicalCRITERIA.com","article_publisher":"https:\/\/www.facebook.com\/medicalcriteria\/","article_published_time":"2011-02-23T15:45:23+00:00","article_modified_time":"2025-05-14T19:08:25+00:00","author":"Guillermo Firman","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Guillermo Firman","Tiempo de lectura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/medicalcriteria.com\/web\/candtc\/#article","isPartOf":{"@id":"https:\/\/medicalcriteria.com\/web\/candtc\/"},"author":{"name":"Guillermo Firman","@id":"https:\/\/medicalcriteria.com\/web\/#\/schema\/person\/ead6734a2f20659131388ba822c7078c"},"headline":"Indicaciones y Contraindicaciones del Tratamiento con Yodo Radiactivo del C\u00e1ncer de Tiroides Diferenciado (CDT)","datePublished":"2011-02-23T15:45:23+00:00","dateModified":"2025-05-14T19:08:25+00:00","mainEntityOfPage":{"@id":"https:\/\/medicalcriteria.com\/web\/candtc\/"},"wordCount":1081,"publisher":{"@id":"https:\/\/medicalcriteria.com\/web\/#organization"},"keywords":["Cancer","contraindicaciones","Contraindications","diferenciado","Differentiated","DTC","indicaciones","Indications","iodo","Radioiodine","Thyroid","tiroides","tratamiento","yodo"],"articleSection":["Oncology"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/medicalcriteria.com\/web\/candtc\/","url":"https:\/\/medicalcriteria.com\/web\/candtc\/","name":"[:es]Indicaciones y Contraindicaciones del Tratamiento con Yodo Radiactivo del C\u00e1ncer de Tiroides Diferenciado (CDT)[:en]Indications and Contraindications Radioiodine Treatment of Differentiated Thyroid Cancer (DTC)[:] - MedicalCRITERIA.com","isPartOf":{"@id":"https:\/\/medicalcriteria.com\/web\/#website"},"datePublished":"2011-02-23T15:45:23+00:00","dateModified":"2025-05-14T19:08:25+00:00","breadcrumb":{"@id":"https:\/\/medicalcriteria.com\/web\/candtc\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medicalcriteria.com\/web\/candtc\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/medicalcriteria.com\/web\/candtc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/medicalcriteria.com\/web\/"},{"@type":"ListItem","position":2,"name":"Indicaciones y Contraindicaciones del Tratamiento con Yodo Radiactivo del C\u00e1ncer de Tiroides Diferenciado (CDT)"}]},{"@type":"WebSite","@id":"https:\/\/medicalcriteria.com\/web\/#website","url":"https:\/\/medicalcriteria.com\/web\/","name":"MedicalCRITERIA.com","description":"Unifying Concepts","publisher":{"@id":"https:\/\/medicalcriteria.com\/web\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medicalcriteria.com\/web\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/medicalcriteria.com\/web\/#organization","name":"MedicalCRITERIA.com","url":"https:\/\/medicalcriteria.com\/web\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/medicalcriteria.com\/web\/#\/schema\/logo\/image\/","url":"https:\/\/medicalcriteria.com\/web\/wp-content\/uploads\/2025\/03\/cropped-mc_1024x500.png","contentUrl":"https:\/\/medicalcriteria.com\/web\/wp-content\/uploads\/2025\/03\/cropped-mc_1024x500.png","width":600,"height":257,"caption":"MedicalCRITERIA.com"},"image":{"@id":"https:\/\/medicalcriteria.com\/web\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/medicalcriteria\/"]},{"@type":"Person","@id":"https:\/\/medicalcriteria.com\/web\/#\/schema\/person\/ead6734a2f20659131388ba822c7078c","name":"Guillermo Firman","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/24f0f68ba780b5b240680962755c6f75e6116e6667394a46e38b7b8fd0a62e9f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/24f0f68ba780b5b240680962755c6f75e6116e6667394a46e38b7b8fd0a62e9f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/24f0f68ba780b5b240680962755c6f75e6116e6667394a46e38b7b8fd0a62e9f?s=96&d=mm&r=g","caption":"Guillermo Firman"},"sameAs":["http:\/\/MedicalCRITERIA.com"]}]}},"modified_by":"Guillermo Firman","_links":{"self":[{"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/posts\/2434","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/comments?post=2434"}],"version-history":[{"count":3,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/posts\/2434\/revisions"}],"predecessor-version":[{"id":9338,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/posts\/2434\/revisions\/9338"}],"wp:attachment":[{"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/media?parent=2434"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/categories?post=2434"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/tags?post=2434"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}